Finished product CCIT failure after process parameter adjustment: CAPA plan that inspectors accept (with effectiveness checks and due dates)
Symptoms or signals that indicate a potential CCIT failure include:Click to read the full article.
Finished Pharmaceutical Products (FPPs)
Finished product blend uniformity failure during PAI / FDA inspection readiness: data integrity review steps for LIMS/EMR/ES and chromatography systems
Blend uniformity failures manifest through various signals that can be observed both on the manufacturing floor and within laboratory settings. Identifying these symptoms promptly can prevent cascade failures within the…
Finished product serialization data mismatch during routine batch release: how to build a deviation package that passes an inspection deep-dive
Symptoms of a serialization data mismatch can manifest in several ways, such as:Click to read the full article.
Finished product impurity increase on stability during stability pull at accelerated conditions: CAPA plan that inspectors accept (with effectiveness checks and due dates)
When engaging in stability studies, especially under accelerated conditions, various symptoms can signal potential quality issues. The most prominent concerns include:Click to read the full article.
Finished product hardness / friability drift during complaint trending review: how to defend specification setting and outlier handling during inspection
Identifying the right signals is the first step in any investigation. In the context of hardness and friability, the following symptoms may indicate underlying problems:Click to read the full article.
Finished product coating non-uniformity during PAI / FDA inspection readiness: how to build a deviation package that passes an inspection deep-dive
Identifying symptoms that indicate coating non-uniformity is crucial to initiating a proper investigation. Symptoms can manifest both visually and through analytical testing methods. Some key signals to look out for…
Finished product stability trend (OOT) during stability pull at accelerated conditions: stability strategy adjustments and packaging risk mitigation steps
Recognizing the symptoms of an OOT stability trend is crucial for timely intervention. Key signals include:Click to read the full article.
Finished product hardness / friability drift during routine batch release: how to defend specification setting and outlier handling during inspection
Identifying the symptoms of hardness or friability drift starts in the manufacturing or quality control laboratory. Common signals include:Click to read the full article.
Finished product nitrosamine risk assessment gap during recall risk assessment: how to build a deviation package that passes an inspection deep-dive
Identifying the signs of a possible nitrosamine risk assessment gap is the first step in a successful investigation. Symptoms may manifest as deviations, Out of Specification (OOS) results, or unexpected…